Corrigendum to “A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway” [Bioact. Mater. 6 2 (February 2021) 375–385]

The authors regret the publication of incorrect fund numbers in the acknowledgment section of the article. The number “cstc2019jcyj-zdxm0033” has been updated as “cstc2019jcyj-zdxmX0028”.

The corrected acknowledgment section is as follows:

This study was supported in part by grants from the National Natural Science Foundation, China (31971242, 31701275), the Natural Science Foundation of Chongqing, China (cstc2020jcjy-msxmX0189), the Chongqing Research Program of Basic Research and Frontier Technology, China (cstc2019jcjy-dxmX0028), Open Fund for Key Laboratory of Biorheological Science and Technology, Ministry of Education, China (CQKLBST-2019-010), Innovation Talent Project of 2020 for Chongqing Primary and secondary School, China (CY200405) and the National Key R&D Program, China (2016YFC1102305). The support from the Chongqing Engineering Laboratory in Vascular Implants, China, the Public Experiment Centre of State Bioindustrial Base (Chongqing) and the National “111 Plan”, China (B06023) are gratefully acknowledged.

The authors would like to apologise for any inconvenience caused.